Skip to page content  Home  Recombinant DNA  Genetics, Health, and Society  Dual Use Research  Clinical Research Policy
  About RAC
  News and Events
  RAC Meetings
  Frequently Asked Questions
  Documents of Interest
  GeMCRIS
  NIH Guidelines
  Informed Consent
  IBC Information
  Educational Materials
 
References
Current SCID Gene Transfer Experience  
   Gaspar HB, Parsley KL, Howe S, King D, Gilmour KC, et al. (2004) Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364:2181-2187.  
   Schmidt M, Hacein-Bey-Abina S, Wissler M, Carlier F, Lim A, et al. (2005) Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial. Blood 105(7):2699-2706.  
Retrovirus Integration and Insertional Mutagenesis  
   Akagi K, Suzuki T, Stephens RM, Jenkins NA and Copeland NG. (2004) RTCGD: retroviral tagged cancer gene database. Nucl Acid Res 32:Database Issue D523-D527.  
   Davé UP, Jenkins NA and Copeland NG. (2004) Gene therapy insertional mutagenesis insights. Science 303:333.  
   von Kalle C, Fehse B, Layh-Schmitt G, Schmidt M, Kelly P and Baum C. (2004 ) Stem cell clonality and genotoxicity in hematopoietic cells: Gene activation side effects should be avoidable. Semin Hematol 41:303-318.  
   Mitchell RS, Beitzel BF, Schroder ARW, Shinn P, Chen H, et al. (2004) Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2(8):e234.  
Bone Marrow Transplantation for SCID  
   Antoine C, Müller S, Cant A, Cavazzana-Calvo M, Veys P, et al. (2003) Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99. Lancet 361:553-560.  
   Barker JN and Wagner JE. (2003) Umbilical cord blood transplantation : Current practice and future innovations. Crit Rev Oncol Hematol 48:35-43.  
   Buckley RH. (2003) Treatment options for genetically determined immunodeficiency. Lancet 361:541.  
   Friedrich W and Müller SM. (2004) Allogeneic stem cell transplantation for treatment of immunodeficiency. Springer Semin Immun 26:109-118.  
   Myers LA, Patel DD, Puck JM and Buckley RH. (2002) Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood 99:872-878.  
   Rao K, Amrolia PJ, Jones A, Cale CM, Naik P, et al. (2005) Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood 105(2):879-885.  
 

Top of Page
 
none
Disclaimer | Privacy Policy | FOIA | Accessibility | Directions to OBA
none
HHS - Home Page Department of Health and Human Services   National Institutes of Health - Home Page National Institutes of Health   N I H - Office of Science Policy Office of Science Policy   USA.gov - government made easy
none
N I H - Office of Biotechnology Activities N I H - Office of Science Policy National Institutes of Health, DHHS